Today is Tuesday, Aug. 11, 2020

Department of


Section of Urology

The University of Cincinnati section of urology has frequently been ranked among the top 50 urology programs in the United States by U.S. News & World Report. Additionally, the section is currently involved in multiple clinical trials evaluating new therapies for prostate cancer and renal cell carcinoma as part of the University of Cincinnati Cancer Institute (UCCI).

Working closely with the Department of Radiology’s Dr. Sadhna Verma, an expert in MRI prostate imaging, we have established a specialized program in MRI-targeted, ultrasound (US) guided prostate biopsy which increases the accuracy and efficiency of the diagnosis of prostate cancer. Targets identified by MRI are marked on saved images and used as an overlay provided by the image fusion technology known as Artemis during US guided biopsy procedures. We have also established a program for using MRI of the prostate in managing nonaggressive prostate cancer with Active Surveillance. Men with low-grade prostate cancer can postpone or avoid prostate surgery or radiation but be monitored and treated should the prostate cancer progress in volume or pathologic grade. Active Surveillance is the first line of management discussed in appropriate cases.

Initially introduced at the West Chester Hospital, our CT-guided percutaneous thermal ablation of renal tumors program has been expanded to include the UC Medical Center working with the Department of Radiology Interventional group headed by Dr. Ross Ristagno. Many patients with small renal lesions can be monitored without treatment. In cases where a renal tumor changes in dimensions or morphology, patients may be treated effectively by thermal therapy using cryoablation to freeze or radiofrequency energy to heat the lesion, thereby avoiding more invasive open or laparoscopic operative procedures. CT imaging technology is used to guide a small needle through the skin and into the kidney to freeze cancerous tissue. Patients are typically discharged the day after surgery, with return to regular activity in two weeks.

In addition to these innovations in diagnosis and treatment, we provide a full range of treatments for urologic cancers including prostate, kidney, bladder, and male genital organs.

Dr. Ayman Mahdy, a fellowship trained specialist in female pelvic medicine and reconstructive surgery, continues to provide advanced video-urodynamics evaluation of voiding dysfunction for both men and women. This state-of-the-art evaluation provides a greater precision in identifying the cause of voiding symptoms and greater assurance that the proper treatment is chosen to fit the individual patient. Dr. Mahdy also offers a myriad of different treatment options (including non- and minimally invasive) for voiding dysfunction, neurogenic bladder and other female pelvic floor disorders.

The division of pediatric urology at the Cincinnati Children’s Hospital Medical Center performs the entire spectrum of pediatric urologic surgery. The world-renowned full-time pediatric urologists practice with Cincinnati Children’s Hospital Medical Center, one of the largest and most prestigious pediatric facilities in the nation, ranked fourth in the nation for urology by U.S. News & World Report for 2020-2021.


Ayman Mahdy, MD, PhD (Interim Chief)
R. Bruce Bracken, MD
Krishnanath Gaitonde, MD
Nilesh Patil, MD
Courtney Plattner, MD
Abhinav Sidana, MD

Pediatric Urology Faculty:

W. Robert DeFoor, Jr., MD
Elizabeth C. Jackson, MD
Eugene Minevich, MD
Paul H. Noh, MD
Pramod P. Reddy, MD
Curtis Sheldon, MD
Brian VanderBrink, MD
Urology 2018 award
Section Director
Ayman Mahdy, MD, PhD
Associate Professor of Clinical Surgery
Director, Voiding Dysfunction and Female Urology 
Interim Director, Section of Urology